As‐Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK ‐air Study
Allergy · 2026-11 · 81 (11) · 4005-4022
DOI: 10.1111/all.70508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, online erschienen am 09.09.2026. Verfasst von Bernardo Sousa-Pinto und 38 weiteren Autor:innen. Beteiligte Einrichtung: MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Pollen, Rhinitis, Allergic, Seasonal, Anti-Allergic Agents, Rhinitis, Allergic. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breathing Together Onlus Association (Associazione Respiriamo Insieme Onlus), Italy, Clinical Research Support Program of the Japanese Society of Allergology, Japan, Espíritu Santo University, Samborondón, Ecuador.
Abstract (Originalsprache)
Background
Patients with allergic rhinitis often use as‐needed medication instead of regular treatment. Using data from the MASK‐air mHealth app, we compared weeks with use of as‐needed versus regular medication on treatment satisfaction and symptom control.
Methods
We assessed data from the MASK‐air app. We compared weeks in the pollen season in which patients reported the use of one same medication during all the days in the week (“regular treatment”) versus those in which patients reported the use of the same single medication (and no other treatments) in at most 4 days per week (“as‐needed treatment”). We built mixed‐effects linear regression models, evaluating the differences between regular and as‐needed treatments on visual analogue scales for symptom control and treatment satisfaction. We performed sensitivity analyses (i) considering a different definition of as‐needed treatment (use of medication ≤ 2 days per week), and (ii) evaluating treatment days preceded by non‐treatment days.
Results
We assessed 2690 weeks (18,830 days, 1042 MASK‐air users). For intranasal corticosteroids (INCS) and fixed combinations of intranasal antihistamines (INAH) + INCS, there were no significant differences between as‐needed versus regular treatments for treatment satisfaction. For oral antihistamines (OAH) and INCS + OAH, results tended to favour as‐needed approaches. For symptom control, we observed either no significant differences between the two approaches or significant differences favouring as‐needed medication use. Similar results were found in the sensitivity analyses.
Conclusion
Some patients use medication regularly and others use it on‐demand. This study shows that both approaches can satisfy patients and result in good disease control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, University of Porto, Porto, Portugal.
- CINTESISRISE-Centre for Health Technology and Services Research, Health Research Network, University of Porto, Porto, Portugal.
- Department of Health Research Methods, Evidence, and Impact and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Clinical Epidemiology and Research Center (CERC), Humanitas University and Humanitas Research Hospital, Milan, Italy.
- Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.
- Center for Rhinology and Allergology, Wiesbaden, Hesse, Germany.
ORCID-Profile: Bernardo Sousa-Pinto, Rafael José Vieira, Ludger Klimek, Ana Margarida Pereira, Mattia Giovannini, Bilun Gemicioglu, Matteo Martini, Michal Ordak, Orathai Jirapongsananuruk, Frederico S Regateiro, Sanna K Toppila-Salmi, Joaquin Sastre, Yi-Kui Xiang, Danilo di Bona, Torsten Zuberbier, Jean Bousquet
Förderung
- Breathing Together Onlus Association (Associazione Respiriamo Insieme Onlus), Italy
- Clinical Research Support Program of the Japanese Society of Allergology, Japan
- Espíritu Santo University, Samborondón, Ecuador
- Finnish Anti-Tuberculosis Association Foundation and Tampere Tuberculosis Foundation
- State funding for Finnish university-level health research
- Fundação ProAR, Brazil
- Global Allergy and Asthma Excellence Network e.V., Germany
- German Allergy Society AeDA (Ärzteverband Deutscher Allergologen), Germany
Zitieren
APA
Sousa-Pinto, B., Vieira, R. J., Bognanni, A., Klimek, L., Pereira, A. M., Amaral, R., Bedbrook, A., Bonadonna, P., Brussino, L., Dykewicz, M. S., Giovannini, M., Gemicioglu, B., Ivancevich, J. C., Kvedariene, V., Marques-Cruz, M., Martini, M., Moreira, A., Niedoszytko, M., Ordak, M., …, & Bousquet, J. (2026). As‐Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK ‐air Study. Allergy, 81(11), 4005-4022. https://doi.org/10.1111/all.70508
Vancouver
Sousa-Pinto B, Vieira RJ, Bognanni A, Klimek L, Pereira AM, Amaral R, et al. As‐Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK ‐air Study. Allergy. 2026;81(11):4005-4022. doi:10.1111/all.70508
BibTeX
@article{SousaPinto2026,
author = {Sousa-Pinto, Bernardo and Vieira, Rafael José and Bognanni, Antonio and Klimek, Ludger and Pereira, Ana Margarida and Amaral, Rita and Bedbrook, Anna and Bonadonna, Patrizia and Brussino, Luisa and Dykewicz, Mark S and Giovannini, Mattia and Gemicioglu, Bilun and Ivancevich, Juan Carlos and Kvedariene, Violeta and Marques-Cruz, Manuel and Martini, Matteo and Moreira, André and Niedoszytko, Marek and Ordak, Michal and Papadopoulos, Nikolaos G and Pfaar, Oliver and Pham-Thi, Nhân and Jirapongsananuruk, Orathai and Regateiro, Frederico S and Toppila-Salmi, Sanna K and Sastre, Joaquin and Taborda-Barata, Luís and Koyuncu, Ilgım Vardaloğlu and Valiulis, Arunas and Ventura, Maria Teresa and Tanjararak, Kangsadarn and Xiang, Yi-Kui and Shamji, Mohamed H and Torres, Maria José and Schünemann, Holger J and di Bona, Danilo and Fonseca, João A and Zuberbier, Torsten and Bousquet, Jean},
title = {As‐Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK ‐air Study},
journal = {Allergy},
year = {2026},
volume = {81},
number = {11},
pages = {4005--4022},
doi = {10.1111/all.70508}
}
EUVIMED